tiprankstipranks
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Germany Market
SBS
STRATEC Biomedical
RESEARCH TOOLSreports
Want to see DE:SBS full AI Analyst Report?

STRATEC Biomedical (SBS) Income Statement

6 Followers

STRATEC Biomedical Income Statement

Last quarter (Q4 2025), STRATEC Biomedical's total revenue was €75.28M, a decrease of -7.43% from the same quarter last year. In Q4, STRATEC Biomedical's net income was €-4.34M. See STRATEC Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Dec 22Dec 21
Total Revenue
€ 250.86M€ 257.62M€ 270.41M€ 274.63M€ 287.33M
Gross Profit
€ 64.22M€ 76.39M€ 68.16M€ 79.49M€ 87.71M
Operating Expenses
€ 55.63M€ 48.20M€ 40.04M€ 37.49M€ 38.08M
Depreciation and Amortization
€ 18.59M€ 19.43M€ 17.69M€ 16.93M€ 18.25M
EBITDA
€ 27.19M€ 47.34M€ 43.16M€ 57.53M€ 66.52M
Operating Income
€ 8.59M€ 28.18M€ 28.12M€ 42.00M€ 49.63M
Other Income/Expenses
€ -3.75M€ -6.17M€ -6.58M€ -2.91M€ -2.80M
Pretax Income
€ 4.85M€ 22.01M€ 21.55M€ 39.09M€ 46.83M
Net Income
€ -242.00K€ 16.02M€ 15.37M€ 29.22M€ 39.96M
Per Share Metrics
Basic EPS
€ -0.02€ 1.32€ 1.26€ 2.41€ 3.30
Diluted EPS
€ -0.02€ 1.32€ 1.26€ 2.40€ 3.28
Weighted Average Shares Outstanding
 12.16M 12.16M 12.16M 12.13M 12.11M
Weighted Average Shares Outstanding (Diluted)
 12.16M 12.16M 12.16M 12.17M 12.18M
Currency in EUR

STRATEC Biomedical Earnings and Revenue History